Square Pharmaceuticals PLC 2025 SR
The report highlights Square Pharmaceuticals PLC's progress during the 2024-2025 period, focusing on its balanced approach to financial discipline and sustainability. Key achievements include being ranked in Bloomberg's 2024 ESG list and receiving the Excellence in Investment Award 2025. The company advanced its environmental goals by planting over 200,000 trees since 2018 and planning a 5 MW solar expansion by 2026. Socially, it reached over 100,000 people through health programs and hired 1,343 new employees. The report also details the integration of IFRS S2 climate-related disclosures and a commitment to reducing emission intensity by 20% by 2027.
Company: Square Pharmaceuticals PLC
Sector: Health Care
Country: Bangladesh
Year: 2025
Type: SR
Pages: 50
Square Pharmaceuticals PLC
Sustainability Report
The report highlights Square Pharmaceuticals PLC's progress during the 2024-2025 period, focusing on its balanced approach to financial discipline and sustainability. Key achievements include being ranked in Bloomberg's 2024 ESG list and receiving the Excellence in Investment Award 2025. The company advanced its environmental goals by planting over 200,000 trees since 2018 and planning a 5 MW solar expansion by 2026. Socially, it reached over 100,000 people through health programs and hired 1,343 new employees. The report also details the integration of IFRS S2 climate-related disclosures and a commitment to reducing emission intensity by 20% by 2027.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
2024 - 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees